News

Physician at Hackensack University Medical Center Leads the first U.S. Clinical Trial of a Promising New Drug to TreatCharcot-Marie-Tooth Disease

Hackensack Meridian Health Hackensack University Medical Center announced that an international phase 3 study of a novel treatment for Charcot-Marie-Tooth (CMT) hereditary neuropathy, which in the United States was led by Florian P. Thomas, M.D., Ph.D, chair of the Neuroscience Institute and the Department of Neurology, and director of the Hereditary Neuropathy Foundation Center of Excellence at Hackensack University Medical Center, yielded positive results.

READ FULL PRESS RELEASE ON HACKENSACKMERIDIANHEALTH.ORG.